220 related articles for article (PubMed ID: 15358473)
1. Factor VII deficiency and its treatment in delivery with recombinant factor VII.
Pehlivanov B; Milchev N; Kroumov G
Eur J Obstet Gynecol Reprod Biol; 2004 Oct; 116(2):237-8. PubMed ID: 15358473
[TBL] [Abstract][Full Text] [Related]
2. [Using recombinant activated coagulation factor VII (NovoSeven) in obstetrics].
Pekhlivanov B; Milchev N; Abrashev B
Akush Ginekol (Sofiia); 2003; 42(6):7-9. PubMed ID: 15067806
[TBL] [Abstract][Full Text] [Related]
3. Factor VII deficiency in pregnancy treated with recombinant factor VIIa.
Eskandari N; Feldman N; Greenspoon JS
Obstet Gynecol; 2002 May; 99(5 Pt 2):935-7. PubMed ID: 11975965
[TBL] [Abstract][Full Text] [Related]
4. Factor VII deficiency and pregnancy: a case report and review of literature.
Zaidi SM; Qureshi RN; Adil SN
J Pak Med Assoc; 2010 Feb; 60(2):136-8. PubMed ID: 20209704
[TBL] [Abstract][Full Text] [Related]
5. Thromboelastographic monitoring of the efficacy of recombinant factor VIIa administration in a parturient with factor VII deficiency.
O'Rourke N; Lee C; Kodali BS; Harnett M
Can J Anaesth; 2006 May; 53(5):528-9. PubMed ID: 16636044
[No Abstract] [Full Text] [Related]
6. [Prophylactic use of a recombinant activated factor VII in delivery haemorrhage by caesarean in a woman with major factor VII deficiency: a case report].
Comes JF; Devignes J; Thiebaugeorges O; Briquel ME; Lecompte T
Ann Biol Clin (Paris); 2011; 69(6):713-9. PubMed ID: 22123573
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy in women with congenital factor VII deficiency.
Kulkarni AA; Lee CA; Kadir RA
Haemophilia; 2006 Jul; 12(4):413-6. PubMed ID: 16834743
[TBL] [Abstract][Full Text] [Related]
8. Prophylaxis of peripartum haemorrhage using recombinant factor VIIa (rfVIIa) in pregnant women with congenital factor VII deficiency: A case report and literature review.
Loddo A; Cornacchia S; Cane FL; Barcellona D; Marongiu F; Melis GB; Angioni S; Paoletti AM; Neri M
Eur J Obstet Gynecol Reprod Biol; 2019 Apr; 235():77-80. PubMed ID: 30831446
[TBL] [Abstract][Full Text] [Related]
9. Management of Labour and Delivery in a Patient With Acquired Factor VII Deficiency With Inhibitor: A Case Report.
Matei A; Dolan S; Andrews J; Rivard GÉ
J Obstet Gynaecol Can; 2016 Feb; 38(2):160-3. PubMed ID: 27032741
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic treatment of a small child with severe factor VII deficiency using repeat dosing from a single vial of recombinant activated factor VII.
Michaels LA; Philipp CS; Eisele J; Pappas H; Saidi P
Pediatr Blood Cancer; 2007 Oct; 49(5):736-9. PubMed ID: 16317734
[TBL] [Abstract][Full Text] [Related]
11. [Anaesthetic management of a parturient with a severe factor VII deficiency: was activated factor VII really necessary?].
Laitselart P; Beaucreux C; Batjom E; Pelletier C; Fontan E; Scherier S; Villevieille T
Ann Fr Anesth Reanim; 2014 May; 33(5):367-8. PubMed ID: 24835539
[No Abstract] [Full Text] [Related]
12. Management of pregnancy in women with factor VII deficiency: A case series.
Lee EJ; Burey L; Abramovitz S; Desancho MT
Haemophilia; 2020 Jul; 26(4):652-656. PubMed ID: 32590881
[TBL] [Abstract][Full Text] [Related]
13. Recombinant-activated coagulation factor VIIa (NovoSeven): current development.
Weiskopf RB
Vox Sang; 2007 May; 92(4):281-8. PubMed ID: 17456151
[TBL] [Abstract][Full Text] [Related]
14. Use of recombinant factor VIIa for hip surgery in a patient with factor-VII deficiency. A case report.
Gopalan PK; Clohisy JC; Cashen AF; Eby CS
J Bone Joint Surg Am; 2007 Feb; 89(2):389-91. PubMed ID: 17272455
[No Abstract] [Full Text] [Related]
15. Successful prophylaxis against intracranial hemorrhage using weekly administration of activated recombinant factor VII in a newborn with severe factor VII deficiency.
Farah RA; Hamod D; Melick N; Giansily-Blaizot M; Sallah S
J Thromb Haemost; 2007 Feb; 5(2):433-4. PubMed ID: 17109737
[No Abstract] [Full Text] [Related]
16. Recombinant factor VIIa, its clinical properties, and the tissue factor pathway of coagulation.
Bosinski TJ; El Solh AA
Mini Rev Med Chem; 2006 Oct; 6(10):1111-7. PubMed ID: 17073711
[TBL] [Abstract][Full Text] [Related]
17. Recombinant factor VIIa for the treatment of congenital factor VII deficiency.
Hunault M; Bauer KA
Semin Thromb Hemost; 2000; 26(4):401-5. PubMed ID: 11092215
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic therapy in a pregnant woman with severe factor VII deficiency.
De Leo V; Ditto A; Morgante G; La Marca A; Massafra C; Guidoni CG
Gynecol Obstet Invest; 2000; 50(4):275-7. PubMed ID: 11093053
[TBL] [Abstract][Full Text] [Related]
19. Recombinant factor VIIa: a general hemostatic agent? Yes.
Roberts HR
J Thromb Haemost; 2004 Oct; 2(10):1691-4. PubMed ID: 15456475
[No Abstract] [Full Text] [Related]
20. Pharmacodynamics of recombinant activated factor VII and plasma-derived factor VII in a cohort of severe FVII deficient patients.
van Geffen M; Mathijssen NC; Holme PA; Laros-van Gorkom BA; van Kraaij MG; Masereeuw R; Peyvandi F; van Heerde WL
Thromb Res; 2013 Jul; 132(1):116-22. PubMed ID: 23731565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
